Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ascendance Biotechnology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10546
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company’s products include human HepatoMune kits, HepatoPac B-CLEAR transporter kits, human HepatoPac kits, rat HepatoPac kits, monkey HepatoPac kits, dog HepatoPac kits, and multi-species HepatoPac kits. It also provides vitro micro-liver cell-based platforms for use in pharmaceutical, safety testing, biotherapeutic and diagnostic product development. Ascendance’ products are created using cell micropatterning technology that plates different cell patterns on industry-standard microwell plates. The company’s products find applications in metabolite identification, preclinical toxicity screening, metabolic stability, transporter-mediated drug uptake and biliary efflux, drug-drug interactions and efficacy assessment. Ascendance is headquartered in Medford, Massachusetts, the US.

Ascendance Biotechnology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ascendance Biotechnology Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Ascendance Biotechnology Raises USD0.2 Million in Financing 11
Partnerships 12
BioTime and Hepregen Form Joint Venture 12
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 13
Qualyst Transporter to Enter into Co-Development Agreement with Hepregen 14
Hepregen Enters Into R&D Agreement With Hamner Institutes 15
Licensing Agreements 16
QPS Enters Into Licensing Agreement With Hepregen For HepatoPac And HepatoMune Products 16
Acquisition 17
BioIVT Acquires Ascendance Biotech 17
Ascendance Biotechnology Inc – Key Competitors 18
Ascendance Biotechnology Inc – Key Employees 19
Ascendance Biotechnology Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ascendance Biotechnology Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ascendance Biotechnology Raises USD0.2 Million in Financing 11
BioTime and Hepregen Form Joint Venture 12
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 13
Qualyst Transporter to Enter into Co-Development Agreement with Hepregen 14
Hepregen Enters Into R&D Agreement With Hamner Institutes 15
QPS Enters Into Licensing Agreement With Hepregen For HepatoPac And HepatoMune Products 16
BioIVT Acquires Ascendance Biotech 17
Ascendance Biotechnology Inc, Key Competitors 18
Ascendance Biotechnology Inc, Key Employees 19
Ascendance Biotechnology Inc, Other Locations 20

List of Figures
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ascendance Biotechnology Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SKF AB:企業の戦略・SWOT・財務分析
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • The Greenbrier Companies, Inc.:企業の戦略・SWOT・財務分析
    The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The Broad Institute Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • GGP Inc:戦略・SWOT・企業財務分析
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Panoptes Pharma GesmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Panoptes Pharma GesmbH (Panoptes Pharma) is a biotech company that develops small molecule based therapies to treat severe eye diseases. The company also develops products in the therapeutic areas of uveitis, viral conjunctivitis, and further indications. It concentrates on a new treatment f …
  • Sunsweet Growers Inc.:戦略・SWOT・企業財務分析
    Sunsweet Growers Inc. - Strategy, SWOT and Corporate Finance Report Summary Sunsweet Growers Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CMI Ltd (CMI):企業の財務・戦略的SWOT分析
    CMI Ltd (CMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Warburg Pincus LLC:企業の戦略・SWOT・財務分析
    Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report Summary Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Forty Seven Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • RSWM Ltd. (RSWM):企業の財務・戦略的SWOT分析
    RSWM Ltd. (RSWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Anika Therapeutics Inc (ANIK):企業の製品パイプライン分析2018
    Summary Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regene …
  • Schindler Holding Ltd.:戦略・SWOT・企業財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cadila Healthcare Ltd (CADILAHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health product …
  • Petroliam Nasional Bhd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroliam Nasional Bhd (Petronas) is an integrated oil and gas company that explores, develops and produces of oil and natural gas in Malaysia and overseas. It also carries out downstream operations such as processing and liquefaction of natural gas; refining and marketing of petroleum produ …
  • Hansa Medical AB (HMED):製薬・医療:M&Aディール及び事業提携情報
    Summary Hansa Medical AB (Hansa Medical) is a biopharmaceutical company that focuses on the development of novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The company's lead project, IdeS is a proprietary antibody-degrading enzyme in late stage clinical development …
  • Zain Group:企業の戦略・SWOT・財務分析
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cardinal Ethanol LLC:企業の戦略的SWOT分析
    Cardinal Ethanol LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Belize Electricity Ltd:企業の戦略的SWOT分析
    Belize Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Consumers Energy Co (CMS PR B):電力:M&Aディール及び事業提携情報
    Summary Consumers Energy Co (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates elec …
  • Levi Strauss & Co:企業の戦略的SWOT分析
    Levi Strauss & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆